Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001190725-18-000021
Filing Date
2018-04-27
Accepted
2018-04-27 17:44:41
Documents
1
Period of Report
2018-04-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 12799
  Complete submission text file 0001190725-18-000021.txt   14283
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Issuer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2910 SEVENTH STREET BERKELEY CA 94710
Business Address
Neal James R (Reporting) CIK: 0001600865 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14710 | Film No.: 18785830